0001209191-15-052410.txt : 20150611
0001209191-15-052410.hdr.sgml : 20150611
20150611181713
ACCESSION NUMBER: 0001209191-15-052410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150610
FILED AS OF DATE: 20150611
DATE AS OF CHANGE: 20150611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herman Melanie J
CENTRAL INDEX KEY: 0001605325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 15927022
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-10
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001605325
Herman Melanie J
11119 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
Interim CFO
Common Stock
2015-06-10
4
M
0
1500
11.91
A
4486
D
Common Stock
2015-06-10
4
M
0
875
21.92
A
5361
D
Common Stock
2015-06-10
4
M
0
1750
68.48
A
7111
D
Common Stock
2015-06-10
4
S
0
4125
93.50
D
2986
D
Employee Stock Option (right to buy)
11.91
2015-06-10
2015-06-10
4
M
0
1500
0.00
D
2022-01-03
Common Stock
1500
875
D
Employee Stock Option (right to buy)
21.92
2015-06-10
2015-06-10
4
M
0
875
0.00
D
2023-02-15
Common Stock
875
1312
D
Employee Stock Option (right to buy)
68.48
2015-06-10
2015-06-10
4
M
0
1750
0.00
D
2024-04-01
Common Stock
1750
4250
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.50 to $93.515, inclusive. The reporting person undertakes to provide, upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 01/03/2012.
Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 02/15/2013.
Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 04/01/2014.
/s/ Charles S. Berkman, For: Melanie J. Herman
2015-06-11